跳至主要内容
临床试验/ACTRN12622000551796
ACTRN12622000551796招募中未知

High flow humidified nasal oxygen for prevention of hypoxaemia associated with remifentanil patient controlled analgesia (PCA) in labouring people – a safety and feasibility study

Department of Anaesthesia, The Royal Women's Hospital - Parkville0 个研究点目标入组 40 人开始时间: 2022年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • People (20 in each group) in labour, expecting live birth, term pregnancy more than or equal to 37 weeks gestation, singleton pregnancy, no cardiac or respiratory disease, no previous caesarean section

排除标准

  • Second stage of labour, significant nasal pathology, severe systemic disease (American Society of Anesthesiologists (ASA) physical status score of 3 or more), preeclampsia or sepsis, opioid allergy, inability to understand protocol instructions, substance abuse disorder, any administration of intramuscular opioid in the last 24 hours

研究者

发起方
Department of Anaesthesia, The Royal Women's Hospital - Parkville

相似试验